Can I take irbesartan while pregnant or breastfeeding?
A plain-words look at what the NHS, the US drug label and LactMed say about irbesartan.
In short
Pregnancy: Let your doctor know if you're pregnant or planning a pregnancy.
Breastfeeding: Let your doctor know if you're breastfeeding.
Your doctor, midwife or pharmacist can help you decide.
What this means for you
Pregnancy
- While you're pregnant, your doctor will usually suggest another medicine.
- Keep taking irbesartan unless they tell you to stop.
Breastfeeding
- Irbesartan is not normally used during breastfeeding.
- Your doctor will usually suggest a different medicine instead.
Talk to your doctor or pharmacist
This page is educational, not advice for your own situation. Talk to your doctor, midwife or pharmacist before you start, stop or change any medicine in pregnancy or while breastfeeding.
The details: what each source says
Irbesartan in pregnancy
The NHS says
Let your doctor know if you're pregnant or planning a pregnancy.
While you're pregnant, your doctor will usually suggest another medicine. Keep taking irbesartan unless they tell you to stop.
In our words, from the NHS page Irbesartan (nhs.uk). Contains public sector information licensed under the Open Government Licence v3.0 (OGL v3.0). The NHS does not endorse this site.
The US drug label says
8.1 Pregnancy Pregnancy Category D Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations. Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. When pregnancy is detected, discontinue irbesartan as soon as possible. These adverse outcomes are usually associated with use of these drugs in the second and third trimesters of pregnancy. Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. Appropriate management of maternal hypertension during pregnancy is important to optimize outcomes for both mother and fetus. In the unusual case that there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system for a particular patient, apprise the mother of the potential risk to the fetus.
Prescribing label, section “8.1 Pregnancy” (opening excerpt): Irbesartan (oral), Bryant Ranch Prepack. Read the full section on DailyMed. Quoted verbatim; US labels are written for US prescribers and patients.
More on irbesartan in pregnancy: Bumps (Best Use of Medicines in Pregnancy) leaflet (external site).
Irbesartan while breastfeeding
The NHS says
Let your doctor know if you're breastfeeding.
Irbesartan is not normally used during breastfeeding. Your doctor will usually suggest a different medicine instead.
In our words, from the NHS page Irbesartan (nhs.uk). Contains public sector information licensed under the Open Government Licence v3.0 (OGL v3.0). The NHS does not endorse this site.
LactMed says
Because no information is available on the use of irbesartan during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
“Summary of Use during Lactation”, LactMed record “Irbesartan” (LM728), quoted verbatim. Everything LactMed reports about Irbesartan while breastfeeding.
What these words mean
- metabolite
- a substance made when the body breaks down a medicine
Definitions adapted from the NCI Dictionary of Cancer Terms (National Cancer Institute).
The US prescribing label says
Nursing Mothers It is not known whether irbesartan is excreted in human milk, but irbesartan or some metabolite of irbesartan is secreted at low concentration in the milk of lactating rats. Because of the potential for adverse effects on the nursing infant, discontinue nursing or discontinue irbesartan.
Prescribing label, section “Nursing Mothers”: Irbesartan (oral), Bryant Ranch Prepack. Label on DailyMed. Quoted verbatim; US labels are written for US prescribers and patients.
Other names
UK brand names (per the NHS): Aprovel.
Sources
- NHS, Irbesartan (nhs.uk), page last reviewed 5 June 2026. Paraphrased. Contains public sector information licensed under the Open Government Licence v3.0.
- US drug label: Irbesartan (oral), Bryant Ranch Prepack, human prescription drug, label effective 9 June 2026, set ID 21dd9a41-93c7-470c-94ed-f4c24e3d5633. DailyMed (National Library of Medicine). Public domain; quoted verbatim.
- Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development (NICHD), via NCBI Bookshelf, record “Irbesartan” (LM728), bulk release of 22 September 2026. LactMed on NCBI Bookshelf. Public domain; quoted verbatim. LactMed is a registered trademark of the U.S. Department of Health and Human Services.
- Bumps (Best Use of Medicines in Pregnancy), UK Teratology Information Service: Bumps (Best Use of Medicines in Pregnancy) leaflet. Linked, not reproduced.
Sources checked 26 September 2026. How we source and check every page.
Educational summary of named sources, not medical advice.
